A Randomized Placebo-controlled Trial to Evaluate the Safety and Immunogenicitiy of the COVID-19 Vaccine

Condition:   COVID-19 Interventions:   Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose;   Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose;   Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose;   Other: Placebo Sponsors:   Institut Pasteur;   Themis Bioscience GmbH;   Coalition for Epidemic Preparedness Innovations (CEPI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials